Clinical trials
Recruiting Phase 2 Glioma trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
26 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2016 | 1 |
| 2019 | 1 |
| 2022 | 2 |
| 2023 | 4 |
| 2024 | 7 |
| 2025 | 4 |
| 2026 | 7 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 26 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Nationwide Children's Hospital | 3 |
| Ashish Shah | 1 |
| Black Diamond Therapeutics, Inc. | 1 |
| Centre Oscar Lambret | 1 |
| Clinica Universidad de Navarra, Universidad de Navarra | 1 |
| Darell Bigner | 1 |
| Fore Biotherapeutics | 1 |
| HighField Biopharmaceuticals Corporation | 1 |
| Marzieh Ebrahimi | 1 |
| Memorial Sloan Kettering Cancer Center | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Glioma | 26 |
| Glioblastoma | 12 |
| Astrocytoma | 8 |
| Brain Neoplasms | 6 |
| Diffuse Intrinsic Pontine Glioma | 4 |
| Oligodendroglioma | 4 |
| Central Nervous System Neoplasms | 2 |
| Ependymoma | 2 |
| Gastrointestinal Stromal Tumors | 2 |
| Medulloblastoma | 2 |
Trials
Showing 1 to 25 of 26. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.